Kidney transplantation alone in ESRD patients with hepatitis C cirrhosis

Transplantation

Volumn 94, Issue 3, 2012, Pages 250-254

  Paramesh, Anil S ^a   Davis, John Y ^a   Mallikarjun, Chaitanya ^a   Zhang, Rubin ^a   Cannon, Robert ^b   Shores, Nathan ^a   Killackey, Mary T ^a   McGee, Jennifer ^a   Saggi, Bob H ^a   Slakey, Douglas P ^a   Balart, Luis ^a   Buell, Joseph F ^a  

^a TULANE UNIVERSITY MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Cirrhosis; Hepatic portal venous gradient; Hepatitis C; Kidney transplant

Indexed keywords

ALBUMIN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTATIC LIVER CELL CARCINOMA; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; FIBROSIS; GRAFT SURVIVAL; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84864655639     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318255f890     Document Type: Article

References (23)

1. Sterling RK, Sanyal AJ, Luketic VA, et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 3576.
2. Morales JM, Campistol JM, Dominguez-Gill B. Hepatitis C virus infection and kidney transplantation. Semin Nephrol 2002; 22: 365.
3. Wells JT, Lucey MR, Said A. Hepatitis C in transplant recipients of solid organs, other than livers. Clin Liver Dis 2006; 10: 901.
4. Giordano HM, Franca AVC, Meirelles L, et al. Chronic liver disease in kidney recipients with hepatitis C infection. Clin Transpl 2003; 17: 195.
5. Martin P, Carter D, Fabrizi F, et al. Histopathological features of hepatitisC in renal transplant candidates. Transplantation 2000; 69: 1479.
6. Eason JD, Gonwa TA, Davis CL, et al. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008; 8: 2243.
7. Zylberberg H, Nalpas B, Carnot F, et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. NephrolDial Transplant 2002; 17: 129.
8. Kamar N, Rostaing L, Selves J, et al. Natural history of hepatitis C virusYrelated fibrosis after renal transplantation.AmJ Transplant 2005; 5: 1704.
9. Roth D, Reddy KR, Kupin W, et al. Long-term impact of HCV on clinical outcomes and liver histology in kidney recipients. Am J Transplant 2004; A478: 289.
10. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3.
11. Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplant candidates; clinical practice guidelines. Am J Transplant 2001; 2(suppl 1): 5.
12. Mouquet C, Mathurin P, Sylla C, et al. Hepatic cirrhosis and kidney transplant outcome. Transplant Proc 1997; 29: 2406. (Pubitemid 27373761)
13. Campbell MS, Constantinescu S, Furth EE, et al. Effects of hepatitis CYinduced liver fibrosis on survival in kidney transplant recipients. Dig Dis Sci 2007; 52: 2501.
14. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list. JAMA 2004; 291: 1871.
15. Ripoll C, Groszmann R, Garcia-Tsao G, et al. Portal hypertension collaborative group. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481.
16. Huraib S, Iqbal A, Tanimu D, Abdullah A. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Am J Nephrol 2001; 21: 435.
17. Kim E, Ko HH, Yoshida EM. Treatment issues surrounding hepatitis C in renal transplantation: a review. Ann Hepatol 2011; 10: 5.
18. Kokoglu OF, Ucmak H, Hosuglu S, et al. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol 2006; 21: 575.
19. Maluf DG, Archer KJ, Mas VR. Kidney grafts from HCV positive donors: advantages and disadvantages. Transplant Proc 2010; 42: 2346.
20. Morales JM, Campistol JM, Dominguez-Gil B, et al. Long-term experience with kidney transplantation from hepatitis CYpositive donors into hepatitis CYpositive recipients. Am J Transplant 2010; 10: 2453.
21. Natov SN, Lau JY, Ruthazer R, et al. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1999; 56: 700.
22. Killackey MT, Fargen K, Islam T, et al. Successful use of hepatitis C positive kidneys for transplantation: caution on the use of older donors. Hepatology 2007; 46: 892A.
23. Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis CYrelated advanced liver disease. Gastroenterology 2009; 136: 138.